Correlation Between Tissue Regenix and AIM ImmunoTech

Can any of the company-specific risk be diversified away by investing in both Tissue Regenix and AIM ImmunoTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tissue Regenix and AIM ImmunoTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tissue Regenix Group and AIM ImmunoTech, you can compare the effects of market volatilities on Tissue Regenix and AIM ImmunoTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tissue Regenix with a short position of AIM ImmunoTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tissue Regenix and AIM ImmunoTech.

Diversification Opportunities for Tissue Regenix and AIM ImmunoTech

-0.43

Correlation Coefficient

Tissue Regenix  AIM ImmunoTech

Very good diversification

The 3 months correlation between Tissue and AIM is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Tissue Regenix Group and AIM ImmunoTech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AIM ImmunoTech and Tissue Regenix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tissue Regenix Group are associated (or correlated) with AIM ImmunoTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AIM ImmunoTech has no effect on the direction of Tissue Regenix i.e., Tissue Regenix and AIM ImmunoTech go up and down completely randomly.

Pair Corralation between Tissue Regenix and AIM ImmunoTech

Assuming the 90 days trading horizon Tissue Regenix is expected to generate 9.69 times less return on investment than AIM ImmunoTech. But when comparing it to its historical volatility, Tissue Regenix Group is 2.71 times less risky than AIM ImmunoTech. It trades about 0.03 of its potential returns per unit of risk. AIM ImmunoTech is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  20.00  in AIM ImmunoTech on October 6, 2024 and sell it today you would earn a total of  2.00  from holding AIM ImmunoTech or generate 10.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.0%
Values	Daily Returns

Tissue Regenix Group  vs.  AIM ImmunoTech

Tissue Regenix Group

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Tissue Regenix Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Tissue Regenix may actually be approaching a critical reversion point that can send shares even higher in February 2025.

AIM ImmunoTech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AIM ImmunoTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Tissue Regenix and AIM ImmunoTech

The main advantage of trading using opposite Tissue Regenix and AIM ImmunoTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tissue Regenix position performs unexpectedly, AIM ImmunoTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AIM ImmunoTech will offset losses from the drop in AIM ImmunoTech's long position.

The idea behind Tissue Regenix Group and AIM ImmunoTech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.